Cargando…
Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step
Infections account for significant morbidity and mortality in liver cirrhosis and most are related to the gut microbiome. Fecal dysbiosis, characterized by an overgrowth of potentially pathogenic bacteria and a decrease in autochthonous non-pathogenic bacteria, becomes prominent with the progression...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
XIA & HE Publishing Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606971/ https://www.ncbi.nlm.nih.gov/pubmed/28936406 http://dx.doi.org/10.14218/JCTH.2017.00008 |